BioCentury | Dec 21, 2020
Translation in Brief

Reversible control of CAR expression; plus an inflammation-reducing mAb, two intranasal COVID-19 treatments and more

...named InvisiMask.Intranasal lentiviral vaccine protects against SARS-CoV-2 infectionAlso in a bioRxiv preprint, researchers from the Institut Pasteur...
...spike protein Danielle Golovin Revlimid, lenalidomide (cdc 501, CC-5013) Theravectys S.A. Novartis Institutes for BioMedical Research Regeneron Pharmaceuticals Inc. Eureka Therapeutics Inc. Institut Pasteur CD19 Interleukin-1...
BioCentury | Aug 1, 2020
Product Development

Merck looks to lower barriers to COVID-19 vaccination with oral approach

Though Merck trails COVID-19 vaccine front-runners, Roger Perlmutter believes that using oral delivery will add a route of administration to the growing armamentarium that could give greater accessibility, in particular for older people. The pharma...
BioCentury | Jul 13, 2020
Targets & Mechanisms

Verge puts ALS target through COVID-19 paces, leaning on preclinical partners

...screening involves testing the compounds’ antiviral activity in human lung and intestinal cell lines at Institut Pasteur...
BioCentury | May 29, 2020
Distillery Therapeutics

Treating malaria with auphen, an inhibitor of the host membrane channel AQP3

...et al. Cell Chem. Biol. ; published online April 23, 2020 doi:10.1016/j.chembiol.2020.03.009 CONTACT: Benoît Witkowski, Institut Pasteur...
...CONTACT: Emily R. Derbyshire, Duke University Medical Center, Durham, N.C. email: emily.derbyshire@duke.edu Claire Quang Duke University Medical Center Institut Pasteur...
BioCentury | May 26, 2020
Deals

With trio of COVID deals, Merck takes a page from its Ebola strategy

...COVID-19 vaccine candidate (see “€40M Round” ). Themis is developing its COVID-19 vaccine candidate with Institut Pasteur...
BioCentury | Feb 1, 2020
Preclinical News

Cellular fluorescence assay to assess allosteric modulator potency in drug discovery

...that the compounds inhibit dimerization in cells. Changeux is an emeritus professor of neuroscience at Institut Pasteur...
...at least one company has approached them to test compounds using FCCS. Inhua Muijrers-Chen, Associate Editor Karolinska Institute Institut Pasteur UCSD Oligodendrocyte...
BioCentury | Jul 18, 2019
Emerging Company Profile

DNA Script: enzymatic DNA synthesis

...enabling researchers to synthesize their own DNA fragments. Its IP, originating at and co-owned by Institut Pasteur...
...Clinical status: NA Founded: 2014 by Thomas Ybert, Sylvain Gariel and Xavier Godron University collaborators: Institut Pasteur...
...Biotechnologies Inc., Berkeley, Calif. DNA Script A/S, Paris, France Dynamic Combinatorial Chemistry LLC, Gainesville, Fla. Institut Pasteur...
BioCentury | Jun 5, 2019
Translation in Brief

New Therapeutic Targets and Biomarkers: May 2019

...could help treat influenza A virus infection Paris Descartes University ; Grenoble Alpes University ; Institut Pasteur...
BioCentury | Jun 5, 2019
Company News

June 5 Company Quick Takes: Enzyvant's athymia candidate gets Priority review; plus Alnylam, Corbin and Institute Pasteur

...green light to norovirus vaccine clinical trial China's National Medical Products Administration (NMPA) has given Institut Pasteur...
...Ubiquitin specific peptidase 15 Elizabeth S. Eaton, Staff Writer givosiran (ALN-AS1) RVT-802 Alnylam Pharmaceuticals Inc. Corbin Therapeutics Inc. Enzyvant Sciences GmbH Institut Pasteur...
BioCentury | May 14, 2019
Distillery Therapeutics

Pyridopyrimidine-based inhibitors of the IK-SMU1 interaction for influenza

...University, Grenoble, France email: thibaut.crepin@ibs.fr CONTACT: Nadia Naffakh, Institut Pasteur, Paris, France email: nadia.naffakh@pasteur.fr Hongjiang Li Grenoble Alpes University Institut Pasteur Paris...
Items per page:
1 - 10 of 137
BioCentury | Dec 21, 2020
Translation in Brief

Reversible control of CAR expression; plus an inflammation-reducing mAb, two intranasal COVID-19 treatments and more

...named InvisiMask.Intranasal lentiviral vaccine protects against SARS-CoV-2 infectionAlso in a bioRxiv preprint, researchers from the Institut Pasteur...
...spike protein Danielle Golovin Revlimid, lenalidomide (cdc 501, CC-5013) Theravectys S.A. Novartis Institutes for BioMedical Research Regeneron Pharmaceuticals Inc. Eureka Therapeutics Inc. Institut Pasteur CD19 Interleukin-1...
BioCentury | Aug 1, 2020
Product Development

Merck looks to lower barriers to COVID-19 vaccination with oral approach

Though Merck trails COVID-19 vaccine front-runners, Roger Perlmutter believes that using oral delivery will add a route of administration to the growing armamentarium that could give greater accessibility, in particular for older people. The pharma...
BioCentury | Jul 13, 2020
Targets & Mechanisms

Verge puts ALS target through COVID-19 paces, leaning on preclinical partners

...screening involves testing the compounds’ antiviral activity in human lung and intestinal cell lines at Institut Pasteur...
BioCentury | May 29, 2020
Distillery Therapeutics

Treating malaria with auphen, an inhibitor of the host membrane channel AQP3

...et al. Cell Chem. Biol. ; published online April 23, 2020 doi:10.1016/j.chembiol.2020.03.009 CONTACT: Benoît Witkowski, Institut Pasteur...
...CONTACT: Emily R. Derbyshire, Duke University Medical Center, Durham, N.C. email: emily.derbyshire@duke.edu Claire Quang Duke University Medical Center Institut Pasteur...
BioCentury | May 26, 2020
Deals

With trio of COVID deals, Merck takes a page from its Ebola strategy

...COVID-19 vaccine candidate (see “€40M Round” ). Themis is developing its COVID-19 vaccine candidate with Institut Pasteur...
BioCentury | Feb 1, 2020
Preclinical News

Cellular fluorescence assay to assess allosteric modulator potency in drug discovery

...that the compounds inhibit dimerization in cells. Changeux is an emeritus professor of neuroscience at Institut Pasteur...
...at least one company has approached them to test compounds using FCCS. Inhua Muijrers-Chen, Associate Editor Karolinska Institute Institut Pasteur UCSD Oligodendrocyte...
BioCentury | Jul 18, 2019
Emerging Company Profile

DNA Script: enzymatic DNA synthesis

...enabling researchers to synthesize their own DNA fragments. Its IP, originating at and co-owned by Institut Pasteur...
...Clinical status: NA Founded: 2014 by Thomas Ybert, Sylvain Gariel and Xavier Godron University collaborators: Institut Pasteur...
...Biotechnologies Inc., Berkeley, Calif. DNA Script A/S, Paris, France Dynamic Combinatorial Chemistry LLC, Gainesville, Fla. Institut Pasteur...
BioCentury | Jun 5, 2019
Translation in Brief

New Therapeutic Targets and Biomarkers: May 2019

...could help treat influenza A virus infection Paris Descartes University ; Grenoble Alpes University ; Institut Pasteur...
BioCentury | Jun 5, 2019
Company News

June 5 Company Quick Takes: Enzyvant's athymia candidate gets Priority review; plus Alnylam, Corbin and Institute Pasteur

...green light to norovirus vaccine clinical trial China's National Medical Products Administration (NMPA) has given Institut Pasteur...
...Ubiquitin specific peptidase 15 Elizabeth S. Eaton, Staff Writer givosiran (ALN-AS1) RVT-802 Alnylam Pharmaceuticals Inc. Corbin Therapeutics Inc. Enzyvant Sciences GmbH Institut Pasteur...
BioCentury | May 14, 2019
Distillery Therapeutics

Pyridopyrimidine-based inhibitors of the IK-SMU1 interaction for influenza

...University, Grenoble, France email: thibaut.crepin@ibs.fr CONTACT: Nadia Naffakh, Institut Pasteur, Paris, France email: nadia.naffakh@pasteur.fr Hongjiang Li Grenoble Alpes University Institut Pasteur Paris...
Items per page:
1 - 10 of 137